![Antonio Parente](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Antonio Parente
Direttore/Membro del Consiglio presso Archivel Farma SL
Profilo
Antonio Parente is currently holding multiple director positions in various biotech companies such as Archivel Farma SL, HAWK Biosystems, Kintsugi Therapeutics, Prospera Biotech SL, and AntalGenics SL.
He is also serving as the Co-Deputy Chairman at l'Associació Catalana d'Empreses de Biotecnologia.
Dr. Parente has an undergraduate and doctorate degree from the University of Barcelona and an MBA from Escuela Superior de Administración y Dirección de Empresas.
Posizioni attive di Antonio Parente
Società | Posizione | Inizio |
---|---|---|
Archivel Farma SL
![]() Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Direttore/Membro del Consiglio | 07/09/2011 |
l'Associació Catalana d'Empreses de Biotecnologia
![]() l'Associació Catalana d'Empreses de Biotecnologia Miscellaneous Commercial ServicesCommercial Services l'Associació Catalana d'Empreses de Biotecnologia is business association operating company. It is engaged in promoting health and life sciences activities for biotechnology organizations, business leaders, senior executives, entrepreneurs, investors and journalists. The company was founded in 2006 and is headquartered in Barcelona, Spain. | Direttore/Membro del Consiglio | - |
HAWK Biosystems
![]() HAWK Biosystems Packaged SoftwareTechnology Services Fastbase Solutions SL operates an online cancer diagnostic software platform. The company is based in Derio, Spain. Fernando Aguirre has been the CEO of the Spanish company since 2018. | Direttore/Membro del Consiglio | - |
Kintsugi Therapeutics
![]() Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Antalgenics SL
![]() Antalgenics SL BiotechnologyHealth Technology Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis. | Direttore/Membro del Consiglio | - |
Prospera Biotech SL
![]() Prospera Biotech SL Household/Personal CareConsumer Non-Durables Prospera Biotech SL is a Spanish company that develops innovative solutions for sensitive skin caused by medical treatments and environmental agents. The company is based in Elche, Spain and was founded in 2019. The company's own formulations are free of aggressive agents and suitable for all types of skin. The company specializes in developing cosmetic formulations with innovative neurocosmetics for skin care in sensitive skin with a tendency to atopia, sensitive skins of people who have received chemotherapy and/or radiotherapy, sensitive skins in the intimate parts of the body, and excessive sweating. The CEO is Marta García. | Direttore/Membro del Consiglio | - |
Formazione di Antonio Parente
University of Barcelona | Doctorate Degree |
Escuela Superior de Administración y Dirección de Empresas | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Archivel Farma SL
![]() Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Commercial Services |
l'Associació Catalana d'Empreses de Biotecnologia
![]() l'Associació Catalana d'Empreses de Biotecnologia Miscellaneous Commercial ServicesCommercial Services l'Associació Catalana d'Empreses de Biotecnologia is business association operating company. It is engaged in promoting health and life sciences activities for biotechnology organizations, business leaders, senior executives, entrepreneurs, investors and journalists. The company was founded in 2006 and is headquartered in Barcelona, Spain. | Commercial Services |
HAWK Biosystems
![]() HAWK Biosystems Packaged SoftwareTechnology Services Fastbase Solutions SL operates an online cancer diagnostic software platform. The company is based in Derio, Spain. Fernando Aguirre has been the CEO of the Spanish company since 2018. | Technology Services |
Kintsugi Therapeutics
![]() Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation. | Health Technology |
Prospera Biotech SL
![]() Prospera Biotech SL Household/Personal CareConsumer Non-Durables Prospera Biotech SL is a Spanish company that develops innovative solutions for sensitive skin caused by medical treatments and environmental agents. The company is based in Elche, Spain and was founded in 2019. The company's own formulations are free of aggressive agents and suitable for all types of skin. The company specializes in developing cosmetic formulations with innovative neurocosmetics for skin care in sensitive skin with a tendency to atopia, sensitive skins of people who have received chemotherapy and/or radiotherapy, sensitive skins in the intimate parts of the body, and excessive sweating. The CEO is Marta García. | Consumer Non-Durables |
Antalgenics SL
![]() Antalgenics SL BiotechnologyHealth Technology Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis. | Health Technology |
- Borsa valori
- Insiders
- Antonio Parente